AV Laboratories Defines a New Skincare Standard for the GLP-1 Era: Molecular Nourishment Designed to Support Skin Through Weight Loss and Beyond
Following the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco, AV Laboratories establishes 360° molecular nourishment as an essential skincare partner to GLP-1-driven transformation. Powered by patented AVL SOM3® technology, the brand’s approach supports the appearance of hydrated, resilient, younger-looking skin as the body moves through weight loss.
As GLP-1 medications continue to reshape the global conversation around weight loss, metabolic health, and long-term wellness, AV Laboratories brought a new skincare standard to the Aesthetic & Anti-Aging Medicine World Congress in Monaco: topical molecular nourishment designed to support the appearance of healthy, resilient, younger-looking skin throughout the weight loss journey.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602498086/en/ AV Laboratories Defines a New Skincare Standard for the GLP-1 Era: Molecular Nourishment Designed to Support Skin Through Weight Loss and Beyond
At the conference, AV Laboratories joined the global aesthetic medicine conversation with a clear message: as GLP-1s transform the way patients approach weight loss and metabolic health, skincare must evolve to support the visible quality of the skin through that transformation. The brand shared its 360° molecular nourishment approach with physicians, aesthetic professionals, and clinic leaders, highlighting the role patented AVL SOM3® technology can play in supporting hydrated, resilient, younger-looking skin.
